EODData

FRA, AYJ0: VALNEVA SE SP.ADS/2

30 Dec 2025
LAST:

7.300

CHANGE:
 0.10
OPEN:
7.300
HIGH:
7.300
ASK:
0.000
VOLUME:
239
CHG(%):
1.39
PREV:
7.200
LOW:
7.300
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Dec 257.3007.3007.3007.300239
29 Dec 256.9507.2006.9507.2008
23 Dec 256.4507.0506.4506.950172
22 Dec 256.4006.8506.4006.8502.8K
19 Dec 256.8506.8506.6506.6502.8K
18 Dec 256.2506.8006.2506.8005
17 Dec 256.3006.9506.3006.9505
16 Dec 256.4507.1006.4507.1005
15 Dec 256.6006.6506.6006.6505
12 Dec 256.8007.4506.7507.4505

PROFILE

Name:VALNEVA SE SP.ADS/2
About:Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, a diarrheal infection caused by Shigella bacteria; VLA1601, a vaccine candidate targeting the Zika virus, a mosquito-borne viral disease; VLA1554, a vaccine candidate targeting human metapneumovirus; VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. The company was founded in 1998 and is based in Saint-Herblain, France.
Sector:Healthcare
Industry:Biotechnology
Address:6 rue Alain Bombard, Saint-Herblain, France, 44800
Website:https://valneva.com
ISIN:US92025Y1038

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:63.89 
Forward P/E:-14.54 
PEG Ratio:-14.54 
Price to Sales:3.49 
Price to Book:7.01 
Profit Margin:-0.34 
Operating Margin:-0.22 
Return on Assets:-0.07 
Return on Equity:-0.38 
Revenue:196.33M 
EBITDA:35.01M 
Shares:85.03M 
Market Cap:620.73M 

TECHNICAL INDICATORS

MA5:6.994.4%
MA10:6.994.4%
MA20:7.191.5%
MA50:7.492.6%
MA100:7.918.3%
MA200:6.728.7%
STO9:100.00 
STO14:72.22
RSI14:46.67
WPR14:-27.78
MTM14:-0.25
ROC14:-0.03 
ATR:0.51 
Week High:7.300.0%
Week Low:6.4513.2%
Month High:7.958.9%
Month Low:6.258.7%
Year High:10.5043.8%
Year Low:3.9087.0%
Volatility:21.13